Screener
CytomX Therapeutics CTMX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's prepaid & other current?
- CytomX Therapeutics (CTMX) reported prepaid & other current of $4.46M in Q2 2026.
- How has CytomX Therapeutics's prepaid & other current changed year-over-year?
- CytomX Therapeutics's prepaid & other current decreased by 4.3% year-over-year, from $4.67M to $4.46M.
- What is the long-term trend for CytomX Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), CytomX Therapeutics's prepaid & other current has grown at a -7.3% compound annual growth rate (CAGR), from $7.1M to $4.86M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about CytomX Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude